Full-Time
Zeiss
1,001-5,000 employees
Produces optical instruments and medical devices
No salary listed
Mid
Company Does Not Provide H1B Sponsorship
Bengaluru, Karnataka, India
- 1-3 years of experience/knowledge in the area of Incident handling, alert tracking, change management.
- Good understanding of network protocols, ports, and common services such as network and application layer protocols.
- Understanding of mainstream operating systems (Windows, Linux, etc.), and commonly used web browsers (Edge, IE, Chrome, Safari, Firefox).
- Good knowledge in incident analysis, evidence collection, documentation, communications, reporting and response.
- Experience in managing Proxy or Firewall. Basic Knowledge in Proxy, VPN, WAF and CDN solutions and network routing and switching.
- First experience in troubleshooting webpages (IE dev tools).
- Possess good communication and documentation skills (fluent English in written and verbal form).
- Identify and analyze potential service disruptions and security breaches in a modern and innovative network infrastructure using log files, performance tests, monitoring systems and ticket systems.
- Resolve service disruptions and security breaches in close cooperation with other departments as well as cloud and service providers.
- Operate the Zeiss Cloud Proxy, VPN, CDN and WAF systems.
- Detect abnormal behavior, analyze for potential threats, and respond to them in a timely manner.
- Support rotational 24x7 operational shifts.
ZEISS specializes in optics and optoelectronics, providing a wide range of products for medical professionals, industrial manufacturers, and consumers. Their offerings include high-precision optical instruments, medical devices, and equipment for semiconductor manufacturing. ZEISS also produces vision care products, such as corrective lenses and eye health consultations. The company stands out from competitors by combining expertise in various fields, ensuring high-quality solutions tailored to different markets. With a strong commitment to sustainability, ZEISS aims to reduce carbon emissions and utilize renewable energy in its operations.
Company Size
1,001-5,000
Company Stage
Growth Equity (Non-Venture Capital)
Total Funding
$14.9M
Headquarters
Oberkochen, Germany
Founded
2001
Simplify's Take
What believers are saying
- Increased demand for AI-based digital pathology benefits ZEISS's medical technology segment.
- Collaboration with Artec 3D enhances ZEISS's industrial quality and research offerings.
- ZEISS MMZ 1 table CMM aligns with the need for precise industrial quality control.
What critics are saying
- Leadership transition may cause uncertainties and strategic shifts impacting operations.
- Increased competition in AI-based digital pathology could affect ZEISS's market position.
- Dependence on strategic partnerships poses risks if collaborations falter.
What makes Zeiss unique
- ZEISS is a global leader in optics and optoelectronics, serving diverse markets.
- The company offers high-precision optical instruments and semiconductor manufacturing equipment.
- ZEISS is committed to sustainability, utilizing renewable electricity and reducing carbon emissions.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Paid Vacation
Performance Bonus
Company News
Thus, Dr. Frank Rohmund was appointed a member of the executive board and head of the Zeiss Semiconductor Manufacturing Technology (SMT) segment effective January 1, 2025, the announcement said.
Mindpeak, the leader in AI-powered pathological solutions, today announced it has raised $15.3 million in a Series A funding round. The round was led
ZEISS is releasing a new version of the standard software for measuring technology on the market: ZEISS CALYPSO 2024 with many new features and improvements for different user groups.
ZEISS has launched the ZEISS MMZ 1 table CMM, designed specifically for large workpieces and applications that require highly accurate contact measurements.
Optics giant ZEISS teams with Artec 3D for 3D scanning software.